Page last updated: 2024-08-26

bosentan anhydrous and apixaban

bosentan anhydrous has been researched along with apixaban in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dalvie, D; Loi, CM; Smith, DA1
Lejnieks, A; Lesina, K; Rudzitis, A; Sablinskis, K; Skride, A1

Other Studies

2 other study(ies) available for bosentan anhydrous and apixaban

ArticleYear
Which metabolites circulate?
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:5

    Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations

2013
First data from Latvian chronic thromboembolic pulmonary hypertension registry.
    European journal of internal medicine, 2016, Volume: 32

    Topics: Adult; Age Distribution; Aged; Anticoagulants; Bosentan; Chronic Disease; Female; Humans; Hypertension, Pulmonary; Incidence; Latvia; Male; Middle Aged; Phenylpropionates; Prevalence; Pulmonary Embolism; Pyrazoles; Pyridazines; Pyridones; Registries; Rivaroxaban; Sex Distribution; Sildenafil Citrate; Sulfonamides; Vasodilator Agents; Warfarin; Young Adult

2016